This clinical trial evaluates whether a supervised community-based exercise and nutrition program is usable and effective for improving cancer survivors' confidence for maintaining their physical activity and nutrition. Cancer survivors often experience problems with the musculoskeletal system (bones, joints, muscles, connective tissue), the cardiopulmonary system (heart, blood vessels and lungs) and the metabolic system (how the body’s cells change food into energy) following treatment. There is substantial evidence that physical activity, diet, and weight management can improve quality of life (emotional and physical well-being) and physical fitness. Information gathered from this study may help researchers determine whether participating in a community-based exercise/nutrition training and education program may improve levels of fitness, cardiovascular health, and quality of life for cancer survivors.
Additional locations may be listed on ClinicalTrials.gov for NCT06565260.
Locations matching your search criteria
United States
New York
Buffalo
Roswell Park Cancer InstituteStatus: Active
Contact: Andrew D. Ray
Phone: 716-845-2381
PRIMARY OBJECTIVE:
I. To assess the feasibility and acceptability of a 12-week supervised community-based exercise/nutrition training and education program for cancer survivors.
SECONDARY OBJECTIVE:
I. To assess the effectiveness of a supervised exercise and nutrition training and education program by evaluating pre-post changes in exercise self-efficacy.
TERTIARY OBJECTIVE:
I. To assess changes in functional performance and quality of life (QoL).
OUTLINE:
Participants take part in a supervised, community-based exercise program consisting of aerobic and resistance exercise over 45-60 minutes twice a week (BIW) for 12 weeks. Beginning at week 2, participants also receive nutrition education and training once a week (QW) for 10 weeks. Participants also wear an activity tracker throughout the study.
After completion of study intervention, participants are followed up at 3 months.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationRoswell Park Cancer Institute
Principal InvestigatorAndrew D. Ray